199 related articles for article (PubMed ID: 28191636)
1. Cancer type predicts alloimmunization following RhD-incompatible RBC transfusions.
Arora K; Kelley J; Sui D; Ning J; Martinez F; Lichtiger B; Tholpady A
Transfusion; 2017 Apr; 57(4):952-958. PubMed ID: 28191636
[TBL] [Abstract][Full Text] [Related]
2. Transfusion of RhD-incompatible blood components in RhD-negative blood marrow transplant recipients.
Asfour M; Narvios A; Lichtiger B
MedGenMed; 2004 Jul; 6(3):22. PubMed ID: 15520646
[TBL] [Abstract][Full Text] [Related]
3. Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients.
Yazer MH; Spinella PC; Sperry J; Triulzi DJ; Leeper C
Transfusion; 2023 May; 63 Suppl 3():S54-S59. PubMed ID: 37067374
[TBL] [Abstract][Full Text] [Related]
4. Rate of RhD-alloimmunization after the transfusion of multiple RhD-positive primary red blood cell-containing products.
Yazer MH; Triulzi DJ; Sperry JL; Seheult JN
Transfusion; 2021 Jul; 61 Suppl 1():S150-S158. PubMed ID: 34269438
[TBL] [Abstract][Full Text] [Related]
5. Absence of D- alloimmunization in AIDS patients receiving D-mismatched RBCs.
Boctor FN; Ali NM; Mohandas K; Uehlinger J
Transfusion; 2003 Feb; 43(2):173-6. PubMed ID: 12559012
[TBL] [Abstract][Full Text] [Related]
6. [Spontaneous antepartal RhD alloimmunization].
Studničková M; Holusková I; Durdová V; Kratochvílová T; Strašilová P; Marková I; Lubušký M
Ceska Gynekol; 2015 Dec; 80(6):401-4. PubMed ID: 26741153
[TBL] [Abstract][Full Text] [Related]
7. Rate of RhD-alloimmunization after the transfusion of RhD-positive red blood cell containing products among injured patients of childbearing age: single center experience and narrative literature review.
Yazer M; Triulzi D; Sperry J; Corcos A; Seheult J
Hematology; 2021 Dec; 26(1):321-327. PubMed ID: 33775237
[TBL] [Abstract][Full Text] [Related]
8. Anti-D alloimmunisation in pregnant women with DEL phenotype in China.
Wang M; Wang BL; Xu W; Fan DD; Peng ML; Pan J; Yao P; Jiang GM; Wan XJ
Transfus Med; 2015 Jun; 25(3):163-9. PubMed ID: 26033335
[TBL] [Abstract][Full Text] [Related]
9. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population.
Wang QP; Dong GT; Wang XD; Gu J; Li Z; Sun AY; Shao CP; Pan ZL; Huang LH; Xie WX; Sun GM; Chen JJ; Pei H; Yang XJ; Shan PN
Blood Transfus; 2014 Apr; 12(2):238-43. PubMed ID: 23399369
[TBL] [Abstract][Full Text] [Related]
10. Intravenous anti-D gammaglobulin for the prevention of rhesus isoimmunization caused by platelet transfusions in patients with malignant diseases.
Heim MU; Böck M; Kolb HJ; Schleuning M; Mempel W
Vox Sang; 1992; 62(3):165-8. PubMed ID: 1319096
[TBL] [Abstract][Full Text] [Related]
11. Detection of anti-D in D- recipients transfused with D+ red blood cells.
Yazer MH; Triulzi DJ
Transfusion; 2007 Dec; 47(12):2197-201. PubMed ID: 17714422
[TBL] [Abstract][Full Text] [Related]
12. [Foetal Rhesus-D typing added to antenatal screening for infectious diseases and erythrocyte immunisation].
van der Ploeg CP; Hirschberg HJ; de Haas M; Abbink F
Ned Tijdschr Geneeskd; 2015; 159():A8315. PubMed ID: 25898866
[TBL] [Abstract][Full Text] [Related]
13. Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion.
Yazer MH; Brunker PA; Bakdash S; Tobian AA; Triulzi DJ; Earnest V; Harris S; Delaney M
Transfusion; 2016 Oct; 56(10):2502-2509. PubMed ID: 27401270
[TBL] [Abstract][Full Text] [Related]
14. Rate of D-alloimmunization in trauma does not depend on the number of RhD-positive units transfused: The BEST collaborative study.
Seheult JN; Callum J; Delaney M; Drake R; Dunbar NM; Harm SK; Hess JR; Jackson BP; Javanbakht A; Moore SA; Murphy MF; Raval JS; Staves J; Tuott EE; Wendel S; Ziman A; Yazer MH;
Transfusion; 2022 Aug; 62 Suppl 1():S185-S192. PubMed ID: 35748692
[TBL] [Abstract][Full Text] [Related]
15. Is it necessary to administer anti-D to prevent RhD immunization after the transfusion of RhD-positive platelet concentrates?
Atoyebi W; Mundy N; Croxton T; Littlewood TJ; Murphy MF
Br J Haematol; 2000 Dec; 111(3):980-3. PubMed ID: 11122163
[TBL] [Abstract][Full Text] [Related]
16. Anti-D alloimmunization in Rh(D) negative adults with severe traumatic injury.
Raval JS; Madden KM; Neal MD; Moore SA
Transfusion; 2021 Jul; 61 Suppl 1():S144-S149. PubMed ID: 34269429
[TBL] [Abstract][Full Text] [Related]
17. Secondary anti-D immunization by Del red blood cells.
Yasuda H; Ohto H; Sakuma S; Ishikawa Y
Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
[TBL] [Abstract][Full Text] [Related]
18. Alloimmunization to RhD antigen in RhD-incompatible haemopoietic cell transplants with non-myeloablative conditioning.
Mijovic A
Vox Sang; 2002 Nov; 83(4):358-62. PubMed ID: 12437524
[TBL] [Abstract][Full Text] [Related]
19. Identification of genetic polymorphisms that predict responder/non-responder profiles to the RhD antigen.
Tan JC; Armstrong NJ; Yuan FF; Flower RL; Dyer WB
Mol Immunol; 2015 Dec; 68(2 Pt C):628-33. PubMed ID: 26505654
[TBL] [Abstract][Full Text] [Related]
20. Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation-wide population study prior to routine antenatal anti-D prophylaxis.
Gudlaugsson B; Hjartardottir H; Svansdottir G; Gudmundsdottir G; Kjartansson S; Jonsson T; Gudmundsson S; Halldorsdottir AM
Transfusion; 2020 Jan; 60(1):175-183. PubMed ID: 31850521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
